Our goal: better treatments for aggressive cancers. We developed PHP53-nb—pairing our 3-NAntC p53-reactivating peptide with the GEN01-AD nanobody platform to restore tumor-suppressing function. Promising results in TNBC and pancreatic cancer.
Robert Gahagen
550 Reserve St. STE 190
Southlake, TX 76092
555-555-5555
contact@phpbiotech.com
September 11, 2026 - PHP Biotech, a US-based biotechnology company specializing in nanobody and translational biotechnology, will participate in the...
Read More
August 03, 2026 - PHP Biotech, a US-based biotechnology company specializing in therapeutic nanobodies for cancer treatment, announced today its...
Read More
